nodes	percent_of_prediction	percent_of_DWPC	metapath
Levorphanol—OPRD1—epilepsy syndrome	0.359	0.567	CbGaD
Levorphanol—OPRM1—epilepsy syndrome	0.274	0.434	CbGaD
Levorphanol—OPRM1—telencephalic ventricle—epilepsy syndrome	0.00539	0.143	CbGeAlD
Levorphanol—OPRD1—ganglion—epilepsy syndrome	0.00492	0.13	CbGeAlD
Levorphanol—OPRM1—ganglion—epilepsy syndrome	0.00336	0.0887	CbGeAlD
Levorphanol—OPRD1—forebrain—epilepsy syndrome	0.00206	0.0546	CbGeAlD
Levorphanol—OPRK1—forebrain—epilepsy syndrome	0.00198	0.0523	CbGeAlD
Levorphanol—OPRD1—telencephalon—epilepsy syndrome	0.0019	0.0502	CbGeAlD
Levorphanol—OPRM1—brainstem—epilepsy syndrome	0.00146	0.0386	CbGeAlD
Levorphanol—OPRM1—forebrain—epilepsy syndrome	0.00141	0.0372	CbGeAlD
Levorphanol—OPRM1—telencephalon—epilepsy syndrome	0.00129	0.0342	CbGeAlD
Levorphanol—OPRD1—head—epilepsy syndrome	0.00118	0.0313	CbGeAlD
Levorphanol—OPRK1—head—epilepsy syndrome	0.00113	0.03	CbGeAlD
Levorphanol—OPRD1—nervous system—epilepsy syndrome	0.00112	0.0296	CbGeAlD
Levorphanol—OPRD1—central nervous system—epilepsy syndrome	0.00108	0.0285	CbGeAlD
Levorphanol—OPRK1—nervous system—epilepsy syndrome	0.00107	0.0284	CbGeAlD
Levorphanol—OPRK1—central nervous system—epilepsy syndrome	0.00103	0.0274	CbGeAlD
Levorphanol—OPRK1—cerebellum—epilepsy syndrome	0.00101	0.0267	CbGeAlD
Levorphanol—OPRM1—midbrain—epilepsy syndrome	0.00093	0.0246	CbGeAlD
Levorphanol—OPRM1—spinal cord—epilepsy syndrome	0.000907	0.024	CbGeAlD
Levorphanol—OPRD1—brain—epilepsy syndrome	0.000857	0.0227	CbGeAlD
Levorphanol—OPRK1—brain—epilepsy syndrome	0.000821	0.0217	CbGeAlD
Levorphanol—OPRM1—head—epilepsy syndrome	0.000806	0.0213	CbGeAlD
Levorphanol—OPRM1—nervous system—epilepsy syndrome	0.000764	0.0202	CbGeAlD
Levorphanol—OPRM1—central nervous system—epilepsy syndrome	0.000736	0.0195	CbGeAlD
Levorphanol—OPRM1—brain—epilepsy syndrome	0.000584	0.0154	CbGeAlD
Levorphanol—Levallorphan—OPRM1—epilepsy syndrome	0.000583	0.0882	CrCbGaD
Levorphanol—Pentazocine—OPRD1—epilepsy syndrome	0.000471	0.0712	CrCbGaD
Levorphanol—Butorphanol—OPRD1—epilepsy syndrome	0.000438	0.0662	CrCbGaD
Levorphanol—Dezocine—OPRM1—epilepsy syndrome	0.000394	0.0596	CrCbGaD
Levorphanol—Pentazocine—OPRM1—epilepsy syndrome	0.00036	0.0545	CrCbGaD
Levorphanol—Butorphanol—OPRM1—epilepsy syndrome	0.000335	0.0507	CrCbGaD
Levorphanol—Dextromethorphan—CHRNA2—epilepsy syndrome	0.000306	0.0463	CrCbGaD
Levorphanol—Dextromethorphan—CHRNB2—epilepsy syndrome	0.000299	0.0453	CrCbGaD
Levorphanol—Hydrocodone—OPRD1—epilepsy syndrome	0.000285	0.0431	CrCbGaD
Levorphanol—Dihydrocodeine—OPRM1—epilepsy syndrome	0.000285	0.0431	CrCbGaD
Levorphanol—Hydromorphone—OPRD1—epilepsy syndrome	0.000236	0.0358	CrCbGaD
Levorphanol—Hydrocodone—OPRM1—epilepsy syndrome	0.000218	0.033	CrCbGaD
Levorphanol—Morphine—OPRD1—epilepsy syndrome	0.000201	0.0304	CrCbGaD
Levorphanol—Estrone—SLCO1A2—epilepsy syndrome	0.000195	0.0295	CrCbGaD
Levorphanol—Hydromorphone—OPRM1—epilepsy syndrome	0.000181	0.0274	CrCbGaD
Levorphanol—Dextromethorphan—CHRNA7—epilepsy syndrome	0.000176	0.0266	CrCbGaD
Levorphanol—Dextromethorphan—OPRD1—epilepsy syndrome	0.000169	0.0255	CrCbGaD
Levorphanol—Morphine—OPRM1—epilepsy syndrome	0.000154	0.0233	CrCbGaD
Levorphanol—Estradiol—SLCO1A2—epilepsy syndrome	0.000148	0.0223	CrCbGaD
Levorphanol—Dextromethorphan—CHRNA4—epilepsy syndrome	0.00014	0.0212	CrCbGaD
Levorphanol—Feeling abnormal—Vigabatrin—epilepsy syndrome	0.00014	0.000636	CcSEcCtD
Levorphanol—Hyperhidrosis—Carbamazepine—epilepsy syndrome	0.00014	0.000636	CcSEcCtD
Levorphanol—Arrhythmia—Valproic Acid—epilepsy syndrome	0.000139	0.000635	CcSEcCtD
Levorphanol—Dyspepsia—Zonisamide—epilepsy syndrome	0.000139	0.000634	CcSEcCtD
Levorphanol—Gastrointestinal pain—Vigabatrin—epilepsy syndrome	0.000138	0.000631	CcSEcCtD
Levorphanol—Sweating—Gabapentin—epilepsy syndrome	0.000138	0.000629	CcSEcCtD
Levorphanol—Urticaria—Fosphenytoin—epilepsy syndrome	0.000138	0.000629	CcSEcCtD
Levorphanol—Constipation—Felbamate—epilepsy syndrome	0.000138	0.000629	CcSEcCtD
Levorphanol—Nausea—Lacosamide—epilepsy syndrome	0.000138	0.000628	CcSEcCtD
Levorphanol—Insomnia—Clonazepam—epilepsy syndrome	0.000138	0.000627	CcSEcCtD
Levorphanol—Feeling abnormal—Diazepam—epilepsy syndrome	0.000137	0.000626	CcSEcCtD
Levorphanol—Shock—Lamotrigine—epilepsy syndrome	0.000137	0.000625	CcSEcCtD
Levorphanol—Insomnia—Phenytoin—epilepsy syndrome	0.000137	0.000623	CcSEcCtD
Levorphanol—Gastrointestinal pain—Diazepam—epilepsy syndrome	0.000136	0.000621	CcSEcCtD
Levorphanol—Tachycardia—Lamotrigine—epilepsy syndrome	0.000136	0.00062	CcSEcCtD
Levorphanol—Insomnia—Oxcarbazepine—epilepsy syndrome	0.000136	0.00062	CcSEcCtD
Levorphanol—Visual impairment—Pregabalin—epilepsy syndrome	0.000136	0.000619	CcSEcCtD
Levorphanol—Constipation—Zonisamide—epilepsy syndrome	0.000135	0.000615	CcSEcCtD
Levorphanol—Hypotension—Carbamazepine—epilepsy syndrome	0.000135	0.000615	CcSEcCtD
Levorphanol—Hyperhidrosis—Lamotrigine—epilepsy syndrome	0.000135	0.000614	CcSEcCtD
Levorphanol—Urticaria—Vigabatrin—epilepsy syndrome	0.000135	0.000613	CcSEcCtD
Levorphanol—Dyspepsia—Clonazepam—epilepsy syndrome	0.000134	0.000611	CcSEcCtD
Levorphanol—Abdominal pain—Vigabatrin—epilepsy syndrome	0.000134	0.00061	CcSEcCtD
Levorphanol—Nausea—Clobazam—epilepsy syndrome	0.000134	0.000609	CcSEcCtD
Levorphanol—Tension—Valproic Acid—epilepsy syndrome	0.000133	0.000607	CcSEcCtD
Levorphanol—Dyspepsia—Phenytoin—epilepsy syndrome	0.000133	0.000606	CcSEcCtD
Levorphanol—Feeling abnormal—Felbamate—epilepsy syndrome	0.000133	0.000606	CcSEcCtD
Levorphanol—Dizziness—Acetazolamide—epilepsy syndrome	0.000133	0.000604	CcSEcCtD
Levorphanol—Urticaria—Diazepam—epilepsy syndrome	0.000132	0.000603	CcSEcCtD
Levorphanol—Dyspepsia—Oxcarbazepine—epilepsy syndrome	0.000132	0.000603	CcSEcCtD
Levorphanol—Gastrointestinal pain—Felbamate—epilepsy syndrome	0.000132	0.000601	CcSEcCtD
Levorphanol—Nervousness—Valproic Acid—epilepsy syndrome	0.000132	0.000601	CcSEcCtD
Levorphanol—Pruritus—Propofol—epilepsy syndrome	0.000132	0.000601	CcSEcCtD
Levorphanol—Abdominal pain—Diazepam—epilepsy syndrome	0.000132	0.000601	CcSEcCtD
Levorphanol—Bradycardia—Gabapentin—epilepsy syndrome	0.000132	0.0006	CcSEcCtD
Levorphanol—Flushing—Pregabalin—epilepsy syndrome	0.000131	0.000596	CcSEcCtD
Levorphanol—Muscle spasms—Valproic Acid—epilepsy syndrome	0.000131	0.000595	CcSEcCtD
Levorphanol—Insomnia—Carbamazepine—epilepsy syndrome	0.000131	0.000595	CcSEcCtD
Levorphanol—Constipation—Clonazepam—epilepsy syndrome	0.00013	0.000593	CcSEcCtD
Levorphanol—Feeling abnormal—Zonisamide—epilepsy syndrome	0.00013	0.000593	CcSEcCtD
Levorphanol—Constipation—Phenytoin—epilepsy syndrome	0.000129	0.000589	CcSEcCtD
Levorphanol—Gastrointestinal pain—Zonisamide—epilepsy syndrome	0.000129	0.000589	CcSEcCtD
Levorphanol—Dextromethorphan—OPRM1—epilepsy syndrome	0.000129	0.0195	CrCbGaD
Levorphanol—Pruritus—Midazolam—epilepsy syndrome	0.000129	0.000588	CcSEcCtD
Levorphanol—Constipation—Oxcarbazepine—epilepsy syndrome	0.000129	0.000586	CcSEcCtD
Levorphanol—Urticaria—Felbamate—epilepsy syndrome	0.000128	0.000584	CcSEcCtD
Levorphanol—Abdominal pain—Felbamate—epilepsy syndrome	0.000128	0.000581	CcSEcCtD
Levorphanol—Vomiting—Acetazolamide—epilepsy syndrome	0.000128	0.000581	CcSEcCtD
Levorphanol—Pruritus—Levetiracetam—epilepsy syndrome	0.000127	0.00058	CcSEcCtD
Levorphanol—Dysuria—Topiramate—epilepsy syndrome	0.000127	0.000579	CcSEcCtD
Levorphanol—Dyspepsia—Carbamazepine—epilepsy syndrome	0.000127	0.000579	CcSEcCtD
Levorphanol—Insomnia—Lamotrigine—epilepsy syndrome	0.000126	0.000575	CcSEcCtD
Levorphanol—Arrhythmia—Pregabalin—epilepsy syndrome	0.000126	0.000574	CcSEcCtD
Levorphanol—Urticaria—Zonisamide—epilepsy syndrome	0.000125	0.000572	CcSEcCtD
Levorphanol—Feeling abnormal—Clonazepam—epilepsy syndrome	0.000125	0.000572	CcSEcCtD
Levorphanol—Abdominal pain—Zonisamide—epilepsy syndrome	0.000125	0.000569	CcSEcCtD
Levorphanol—Agitation—Valproic Acid—epilepsy syndrome	0.000125	0.000569	CcSEcCtD
Levorphanol—Visual impairment—Gabapentin—epilepsy syndrome	0.000125	0.000568	CcSEcCtD
Levorphanol—Feeling abnormal—Phenytoin—epilepsy syndrome	0.000125	0.000568	CcSEcCtD
Levorphanol—Gastrointestinal pain—Clonazepam—epilepsy syndrome	0.000124	0.000567	CcSEcCtD
Levorphanol—Feeling abnormal—Oxcarbazepine—epilepsy syndrome	0.000124	0.000565	CcSEcCtD
Levorphanol—Constipation—Carbamazepine—epilepsy syndrome	0.000123	0.000562	CcSEcCtD
Levorphanol—Dizziness—Propofol—epilepsy syndrome	0.000123	0.000561	CcSEcCtD
Levorphanol—Gastrointestinal pain—Oxcarbazepine—epilepsy syndrome	0.000123	0.00056	CcSEcCtD
Levorphanol—Pruritus—Fosphenytoin—epilepsy syndrome	0.000123	0.00056	CcSEcCtD
Levorphanol—Dyspepsia—Lamotrigine—epilepsy syndrome	0.000123	0.000559	CcSEcCtD
Levorphanol—Urticaria—Clonazepam—epilepsy syndrome	0.000121	0.000551	CcSEcCtD
Levorphanol—Dizziness—Midazolam—epilepsy syndrome	0.000121	0.000549	CcSEcCtD
Levorphanol—Tension—Pregabalin—epilepsy syndrome	0.00012	0.000549	CcSEcCtD
Levorphanol—Abdominal pain—Clonazepam—epilepsy syndrome	0.00012	0.000548	CcSEcCtD
Levorphanol—Urticaria—Phenytoin—epilepsy syndrome	0.00012	0.000547	CcSEcCtD
Levorphanol—Palpitations—Valproic Acid—epilepsy syndrome	0.00012	0.000547	CcSEcCtD
Levorphanol—Pruritus—Vigabatrin—epilepsy syndrome	0.00012	0.000546	CcSEcCtD
Levorphanol—Urticaria—Oxcarbazepine—epilepsy syndrome	0.000119	0.000544	CcSEcCtD
Levorphanol—Constipation—Lamotrigine—epilepsy syndrome	0.000119	0.000544	CcSEcCtD
Levorphanol—Nervousness—Pregabalin—epilepsy syndrome	0.000119	0.000543	CcSEcCtD
Levorphanol—Renal failure—Topiramate—epilepsy syndrome	0.000119	0.000543	CcSEcCtD
Levorphanol—Nausea—Acetazolamide—epilepsy syndrome	0.000119	0.000543	CcSEcCtD
Levorphanol—Dizziness—Levetiracetam—epilepsy syndrome	0.000119	0.000542	CcSEcCtD
Levorphanol—Feeling abnormal—Carbamazepine—epilepsy syndrome	0.000119	0.000542	CcSEcCtD
Levorphanol—Abdominal pain—Oxcarbazepine—epilepsy syndrome	0.000119	0.000542	CcSEcCtD
Levorphanol—Vomiting—Propofol—epilepsy syndrome	0.000118	0.00054	CcSEcCtD
Levorphanol—Muscle spasms—Pregabalin—epilepsy syndrome	0.000118	0.000538	CcSEcCtD
Levorphanol—Gastrointestinal pain—Carbamazepine—epilepsy syndrome	0.000118	0.000538	CcSEcCtD
Levorphanol—Pruritus—Diazepam—epilepsy syndrome	0.000118	0.000537	CcSEcCtD
Levorphanol—Rash—Propofol—epilepsy syndrome	0.000117	0.000535	CcSEcCtD
Levorphanol—Dermatitis—Propofol—epilepsy syndrome	0.000117	0.000535	CcSEcCtD
Levorphanol—Vomiting—Midazolam—epilepsy syndrome	0.000116	0.000528	CcSEcCtD
Levorphanol—Feeling abnormal—Lamotrigine—epilepsy syndrome	0.000115	0.000524	CcSEcCtD
Levorphanol—Rash—Midazolam—epilepsy syndrome	0.000115	0.000524	CcSEcCtD
Levorphanol—Dizziness—Fosphenytoin—epilepsy syndrome	0.000115	0.000523	CcSEcCtD
Levorphanol—Dermatitis—Midazolam—epilepsy syndrome	0.000115	0.000523	CcSEcCtD
Levorphanol—Urticaria—Carbamazepine—epilepsy syndrome	0.000115	0.000522	CcSEcCtD
Levorphanol—Vomiting—Levetiracetam—epilepsy syndrome	0.000114	0.000522	CcSEcCtD
Levorphanol—Pruritus—Felbamate—epilepsy syndrome	0.000114	0.00052	CcSEcCtD
Levorphanol—Abdominal pain—Carbamazepine—epilepsy syndrome	0.000114	0.00052	CcSEcCtD
Levorphanol—Gastrointestinal pain—Lamotrigine—epilepsy syndrome	0.000114	0.00052	CcSEcCtD
Levorphanol—Rash—Levetiracetam—epilepsy syndrome	0.000113	0.000517	CcSEcCtD
Levorphanol—Dermatitis—Levetiracetam—epilepsy syndrome	0.000113	0.000517	CcSEcCtD
Levorphanol—Dry mouth—Valproic Acid—epilepsy syndrome	0.000113	0.000515	CcSEcCtD
Levorphanol—Agitation—Pregabalin—epilepsy syndrome	0.000113	0.000514	CcSEcCtD
Levorphanol—Dizziness—Vigabatrin—epilepsy syndrome	0.000112	0.00051	CcSEcCtD
Levorphanol—Confusional state—Valproic Acid—epilepsy syndrome	0.000112	0.000509	CcSEcCtD
Levorphanol—Pruritus—Zonisamide—epilepsy syndrome	0.000112	0.000509	CcSEcCtD
Levorphanol—Urticaria—Lamotrigine—epilepsy syndrome	0.000111	0.000505	CcSEcCtD
Levorphanol—Bradycardia—Topiramate—epilepsy syndrome	0.000111	0.000505	CcSEcCtD
Levorphanol—Nausea—Propofol—epilepsy syndrome	0.000111	0.000504	CcSEcCtD
Levorphanol—Tension—Gabapentin—epilepsy syndrome	0.00011	0.000503	CcSEcCtD
Levorphanol—Vomiting—Fosphenytoin—epilepsy syndrome	0.00011	0.000503	CcSEcCtD
Levorphanol—Abdominal pain—Lamotrigine—epilepsy syndrome	0.00011	0.000502	CcSEcCtD
Levorphanol—Dizziness—Diazepam—epilepsy syndrome	0.00011	0.000502	CcSEcCtD
Levorphanol—Dihydrocodeine—CYP2D6—epilepsy syndrome	0.00011	0.0167	CrCbGaD
Levorphanol—Rash—Fosphenytoin—epilepsy syndrome	0.00011	0.000499	CcSEcCtD
Levorphanol—Dermatitis—Fosphenytoin—epilepsy syndrome	0.000109	0.000499	CcSEcCtD
Levorphanol—Nervousness—Gabapentin—epilepsy syndrome	0.000109	0.000498	CcSEcCtD
Levorphanol—Palpitations—Pregabalin—epilepsy syndrome	0.000108	0.000494	CcSEcCtD
Levorphanol—Nausea—Midazolam—epilepsy syndrome	0.000108	0.000493	CcSEcCtD
Levorphanol—Muscle spasms—Gabapentin—epilepsy syndrome	0.000108	0.000493	CcSEcCtD
Levorphanol—Tachycardia—Valproic Acid—epilepsy syndrome	0.000108	0.000493	CcSEcCtD
Levorphanol—Pruritus—Clonazepam—epilepsy syndrome	0.000108	0.000491	CcSEcCtD
Levorphanol—Vomiting—Vigabatrin—epilepsy syndrome	0.000108	0.000491	CcSEcCtD
Levorphanol—Hyperhidrosis—Valproic Acid—epilepsy syndrome	0.000107	0.000488	CcSEcCtD
Levorphanol—Pruritus—Phenytoin—epilepsy syndrome	0.000107	0.000487	CcSEcCtD
Levorphanol—Nausea—Levetiracetam—epilepsy syndrome	0.000107	0.000487	CcSEcCtD
Levorphanol—Rash—Vigabatrin—epilepsy syndrome	0.000107	0.000487	CcSEcCtD
Levorphanol—Dizziness—Felbamate—epilepsy syndrome	0.000107	0.000486	CcSEcCtD
Levorphanol—Dermatitis—Vigabatrin—epilepsy syndrome	0.000107	0.000486	CcSEcCtD
Levorphanol—Pruritus—Oxcarbazepine—epilepsy syndrome	0.000106	0.000485	CcSEcCtD
Levorphanol—Convulsion—Pregabalin—epilepsy syndrome	0.000106	0.000485	CcSEcCtD
Levorphanol—Vomiting—Diazepam—epilepsy syndrome	0.000106	0.000483	CcSEcCtD
Levorphanol—Rash—Diazepam—epilepsy syndrome	0.000105	0.000479	CcSEcCtD
Levorphanol—Dermatitis—Diazepam—epilepsy syndrome	0.000105	0.000479	CcSEcCtD
Levorphanol—Visual impairment—Topiramate—epilepsy syndrome	0.000105	0.000478	CcSEcCtD
Levorphanol—Dizziness—Zonisamide—epilepsy syndrome	0.000104	0.000476	CcSEcCtD
Levorphanol—Hypotension—Valproic Acid—epilepsy syndrome	0.000104	0.000472	CcSEcCtD
Levorphanol—Agitation—Gabapentin—epilepsy syndrome	0.000103	0.000471	CcSEcCtD
Levorphanol—Nausea—Fosphenytoin—epilepsy syndrome	0.000103	0.00047	CcSEcCtD
Levorphanol—Vomiting—Felbamate—epilepsy syndrome	0.000103	0.000467	CcSEcCtD
Levorphanol—Dry mouth—Pregabalin—epilepsy syndrome	0.000102	0.000466	CcSEcCtD
Levorphanol—Pruritus—Carbamazepine—epilepsy syndrome	0.000102	0.000465	CcSEcCtD
Levorphanol—Rash—Felbamate—epilepsy syndrome	0.000102	0.000464	CcSEcCtD
Levorphanol—Dermatitis—Felbamate—epilepsy syndrome	0.000102	0.000463	CcSEcCtD
Levorphanol—Confusional state—Pregabalin—epilepsy syndrome	0.000101	0.00046	CcSEcCtD
Levorphanol—Flushing—Topiramate—epilepsy syndrome	0.000101	0.00046	CcSEcCtD
Levorphanol—Dizziness—Clonazepam—epilepsy syndrome	0.000101	0.000459	CcSEcCtD
Levorphanol—Nausea—Vigabatrin—epilepsy syndrome	0.000101	0.000458	CcSEcCtD
Levorphanol—Vomiting—Zonisamide—epilepsy syndrome	0.0001	0.000458	CcSEcCtD
Levorphanol—Insomnia—Valproic Acid—epilepsy syndrome	0.0001	0.000457	CcSEcCtD
Levorphanol—Dizziness—Phenytoin—epilepsy syndrome	0.0001	0.000456	CcSEcCtD
Levorphanol—Rash—Zonisamide—epilepsy syndrome	9.96e-05	0.000454	CcSEcCtD
Levorphanol—Palpitations—Gabapentin—epilepsy syndrome	9.95e-05	0.000453	CcSEcCtD
Levorphanol—Dermatitis—Zonisamide—epilepsy syndrome	9.95e-05	0.000453	CcSEcCtD
Levorphanol—Dizziness—Oxcarbazepine—epilepsy syndrome	9.94e-05	0.000453	CcSEcCtD
Levorphanol—Nausea—Diazepam—epilepsy syndrome	9.9e-05	0.000451	CcSEcCtD
Levorphanol—Pruritus—Lamotrigine—epilepsy syndrome	9.87e-05	0.00045	CcSEcCtD
Levorphanol—Shock—Pregabalin—epilepsy syndrome	9.86e-05	0.000449	CcSEcCtD
Levorphanol—Tachycardia—Pregabalin—epilepsy syndrome	9.78e-05	0.000446	CcSEcCtD
Levorphanol—Dyspepsia—Valproic Acid—epilepsy syndrome	9.76e-05	0.000445	CcSEcCtD
Levorphanol—Convulsion—Gabapentin—epilepsy syndrome	9.75e-05	0.000445	CcSEcCtD
Levorphanol—Hyperhidrosis—Pregabalin—epilepsy syndrome	9.69e-05	0.000441	CcSEcCtD
Levorphanol—Vomiting—Clonazepam—epilepsy syndrome	9.68e-05	0.000441	CcSEcCtD
Levorphanol—Vomiting—Phenytoin—epilepsy syndrome	9.61e-05	0.000438	CcSEcCtD
Levorphanol—Rash—Clonazepam—epilepsy syndrome	9.6e-05	0.000437	CcSEcCtD
Levorphanol—Dermatitis—Clonazepam—epilepsy syndrome	9.59e-05	0.000437	CcSEcCtD
Levorphanol—Nausea—Felbamate—epilepsy syndrome	9.58e-05	0.000437	CcSEcCtD
Levorphanol—Vomiting—Oxcarbazepine—epilepsy syndrome	9.56e-05	0.000436	CcSEcCtD
Levorphanol—Dizziness—Carbamazepine—epilepsy syndrome	9.54e-05	0.000435	CcSEcCtD
Levorphanol—Rash—Phenytoin—epilepsy syndrome	9.53e-05	0.000434	CcSEcCtD
Levorphanol—Dermatitis—Phenytoin—epilepsy syndrome	9.52e-05	0.000434	CcSEcCtD
Levorphanol—Rash—Oxcarbazepine—epilepsy syndrome	9.48e-05	0.000432	CcSEcCtD
Levorphanol—Constipation—Valproic Acid—epilepsy syndrome	9.48e-05	0.000432	CcSEcCtD
Levorphanol—Dermatitis—Oxcarbazepine—epilepsy syndrome	9.47e-05	0.000432	CcSEcCtD
Levorphanol—Nausea—Zonisamide—epilepsy syndrome	9.38e-05	0.000427	CcSEcCtD
Levorphanol—Dry mouth—Gabapentin—epilepsy syndrome	9.37e-05	0.000427	CcSEcCtD
Levorphanol—Hypotension—Pregabalin—epilepsy syndrome	9.36e-05	0.000427	CcSEcCtD
Levorphanol—Tension—Topiramate—epilepsy syndrome	9.29e-05	0.000424	CcSEcCtD
Levorphanol—Confusional state—Gabapentin—epilepsy syndrome	9.26e-05	0.000422	CcSEcCtD
Levorphanol—Dizziness—Lamotrigine—epilepsy syndrome	9.22e-05	0.00042	CcSEcCtD
Levorphanol—Nervousness—Topiramate—epilepsy syndrome	9.2e-05	0.000419	CcSEcCtD
Levorphanol—Vomiting—Carbamazepine—epilepsy syndrome	9.18e-05	0.000418	CcSEcCtD
Levorphanol—Feeling abnormal—Valproic Acid—epilepsy syndrome	9.13e-05	0.000416	CcSEcCtD
Levorphanol—Muscle spasms—Topiramate—epilepsy syndrome	9.11e-05	0.000415	CcSEcCtD
Levorphanol—Rash—Carbamazepine—epilepsy syndrome	9.1e-05	0.000415	CcSEcCtD
Levorphanol—Dermatitis—Carbamazepine—epilepsy syndrome	9.09e-05	0.000414	CcSEcCtD
Levorphanol—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	9.06e-05	0.000413	CcSEcCtD
Levorphanol—Insomnia—Pregabalin—epilepsy syndrome	9.06e-05	0.000413	CcSEcCtD
Levorphanol—Nausea—Clonazepam—epilepsy syndrome	9.04e-05	0.000412	CcSEcCtD
Levorphanol—Shock—Gabapentin—epilepsy syndrome	9.04e-05	0.000412	CcSEcCtD
Levorphanol—Nausea—Phenytoin—epilepsy syndrome	8.98e-05	0.000409	CcSEcCtD
Levorphanol—Tachycardia—Gabapentin—epilepsy syndrome	8.97e-05	0.000409	CcSEcCtD
Levorphanol—Nausea—Oxcarbazepine—epilepsy syndrome	8.93e-05	0.000407	CcSEcCtD
Levorphanol—Hyperhidrosis—Gabapentin—epilepsy syndrome	8.88e-05	0.000405	CcSEcCtD
Levorphanol—Vomiting—Lamotrigine—epilepsy syndrome	8.87e-05	0.000404	CcSEcCtD
Levorphanol—Urticaria—Valproic Acid—epilepsy syndrome	8.8e-05	0.000401	CcSEcCtD
Levorphanol—Rash—Lamotrigine—epilepsy syndrome	8.79e-05	0.000401	CcSEcCtD
Levorphanol—Dermatitis—Lamotrigine—epilepsy syndrome	8.79e-05	0.0004	CcSEcCtD
Levorphanol—Abdominal pain—Valproic Acid—epilepsy syndrome	8.76e-05	0.000399	CcSEcCtD
Levorphanol—Agitation—Topiramate—epilepsy syndrome	8.7e-05	0.000397	CcSEcCtD
Levorphanol—Hypotension—Gabapentin—epilepsy syndrome	8.59e-05	0.000391	CcSEcCtD
Levorphanol—Nausea—Carbamazepine—epilepsy syndrome	8.57e-05	0.000391	CcSEcCtD
Levorphanol—Constipation—Pregabalin—epilepsy syndrome	8.57e-05	0.00039	CcSEcCtD
Levorphanol—Hydrocodone—CYP2D6—epilepsy syndrome	8.45e-05	0.0128	CrCbGaD
Levorphanol—Palpitations—Topiramate—epilepsy syndrome	8.37e-05	0.000381	CcSEcCtD
Levorphanol—Insomnia—Gabapentin—epilepsy syndrome	8.31e-05	0.000379	CcSEcCtD
Levorphanol—Nausea—Lamotrigine—epilepsy syndrome	8.28e-05	0.000378	CcSEcCtD
Levorphanol—Feeling abnormal—Pregabalin—epilepsy syndrome	8.26e-05	0.000376	CcSEcCtD
Levorphanol—Estrone—ABCG2—epilepsy syndrome	8.23e-05	0.0125	CrCbGaD
Levorphanol—Convulsion—Topiramate—epilepsy syndrome	8.21e-05	0.000374	CcSEcCtD
Levorphanol—Gastrointestinal pain—Pregabalin—epilepsy syndrome	8.19e-05	0.000373	CcSEcCtD
Levorphanol—Dyspepsia—Gabapentin—epilepsy syndrome	8.09e-05	0.000369	CcSEcCtD
Levorphanol—Urticaria—Pregabalin—epilepsy syndrome	7.96e-05	0.000363	CcSEcCtD
Levorphanol—Abdominal pain—Pregabalin—epilepsy syndrome	7.92e-05	0.000361	CcSEcCtD
Levorphanol—Dry mouth—Topiramate—epilepsy syndrome	7.89e-05	0.000359	CcSEcCtD
Levorphanol—Constipation—Gabapentin—epilepsy syndrome	7.86e-05	0.000358	CcSEcCtD
Levorphanol—Pruritus—Valproic Acid—epilepsy syndrome	7.84e-05	0.000357	CcSEcCtD
Levorphanol—Confusional state—Topiramate—epilepsy syndrome	7.79e-05	0.000355	CcSEcCtD
Levorphanol—Shock—Topiramate—epilepsy syndrome	7.6e-05	0.000347	CcSEcCtD
Levorphanol—Feeling abnormal—Gabapentin—epilepsy syndrome	7.57e-05	0.000345	CcSEcCtD
Levorphanol—Tachycardia—Topiramate—epilepsy syndrome	7.54e-05	0.000344	CcSEcCtD
Levorphanol—Gastrointestinal pain—Gabapentin—epilepsy syndrome	7.51e-05	0.000342	CcSEcCtD
Levorphanol—Hyperhidrosis—Topiramate—epilepsy syndrome	7.47e-05	0.000341	CcSEcCtD
Levorphanol—Dizziness—Valproic Acid—epilepsy syndrome	7.33e-05	0.000334	CcSEcCtD
Levorphanol—Urticaria—Gabapentin—epilepsy syndrome	7.3e-05	0.000333	CcSEcCtD
Levorphanol—Abdominal pain—Gabapentin—epilepsy syndrome	7.26e-05	0.000331	CcSEcCtD
Levorphanol—Hypotension—Topiramate—epilepsy syndrome	7.22e-05	0.000329	CcSEcCtD
Levorphanol—Dextromethorphan—SLC6A4—epilepsy syndrome	7.11e-05	0.0108	CrCbGaD
Levorphanol—Pruritus—Pregabalin—epilepsy syndrome	7.09e-05	0.000323	CcSEcCtD
Levorphanol—Vomiting—Valproic Acid—epilepsy syndrome	7.05e-05	0.000321	CcSEcCtD
Levorphanol—Hydromorphone—CYP2D6—epilepsy syndrome	7e-05	0.0106	CrCbGaD
Levorphanol—Insomnia—Topiramate—epilepsy syndrome	6.99e-05	0.000319	CcSEcCtD
Levorphanol—Rash—Valproic Acid—epilepsy syndrome	6.99e-05	0.000318	CcSEcCtD
Levorphanol—Dermatitis—Valproic Acid—epilepsy syndrome	6.98e-05	0.000318	CcSEcCtD
Levorphanol—Dyspepsia—Topiramate—epilepsy syndrome	6.8e-05	0.00031	CcSEcCtD
Levorphanol—Dextromethorphan—CYP2C19—epilepsy syndrome	6.74e-05	0.0102	CrCbGaD
Levorphanol—Dizziness—Pregabalin—epilepsy syndrome	6.63e-05	0.000302	CcSEcCtD
Levorphanol—Constipation—Topiramate—epilepsy syndrome	6.61e-05	0.000301	CcSEcCtD
Levorphanol—Nausea—Valproic Acid—epilepsy syndrome	6.58e-05	0.0003	CcSEcCtD
Levorphanol—Pruritus—Gabapentin—epilepsy syndrome	6.5e-05	0.000296	CcSEcCtD
Levorphanol—Vomiting—Pregabalin—epilepsy syndrome	6.37e-05	0.00029	CcSEcCtD
Levorphanol—Feeling abnormal—Topiramate—epilepsy syndrome	6.37e-05	0.00029	CcSEcCtD
Levorphanol—Gastrointestinal pain—Topiramate—epilepsy syndrome	6.32e-05	0.000288	CcSEcCtD
Levorphanol—Rash—Pregabalin—epilepsy syndrome	6.32e-05	0.000288	CcSEcCtD
Levorphanol—Dermatitis—Pregabalin—epilepsy syndrome	6.31e-05	0.000288	CcSEcCtD
Levorphanol—Estradiol—ABCG2—epilepsy syndrome	6.24e-05	0.00944	CrCbGaD
Levorphanol—Urticaria—Topiramate—epilepsy syndrome	6.14e-05	0.00028	CcSEcCtD
Levorphanol—Abdominal pain—Topiramate—epilepsy syndrome	6.11e-05	0.000278	CcSEcCtD
Levorphanol—Dizziness—Gabapentin—epilepsy syndrome	6.08e-05	0.000277	CcSEcCtD
Levorphanol—Morphine—CYP2D6—epilepsy syndrome	5.95e-05	0.00901	CrCbGaD
Levorphanol—Nausea—Pregabalin—epilepsy syndrome	5.95e-05	0.000271	CcSEcCtD
Levorphanol—Vomiting—Gabapentin—epilepsy syndrome	5.84e-05	0.000266	CcSEcCtD
Levorphanol—Rash—Gabapentin—epilepsy syndrome	5.79e-05	0.000264	CcSEcCtD
Levorphanol—Dermatitis—Gabapentin—epilepsy syndrome	5.79e-05	0.000264	CcSEcCtD
Levorphanol—Pruritus—Topiramate—epilepsy syndrome	5.47e-05	0.000249	CcSEcCtD
Levorphanol—Nausea—Gabapentin—epilepsy syndrome	5.46e-05	0.000249	CcSEcCtD
Levorphanol—Dizziness—Topiramate—epilepsy syndrome	5.11e-05	0.000233	CcSEcCtD
Levorphanol—Dextromethorphan—CYP2D6—epilepsy syndrome	5e-05	0.00756	CrCbGaD
Levorphanol—Vomiting—Topiramate—epilepsy syndrome	4.91e-05	0.000224	CcSEcCtD
Levorphanol—Estradiol—CYP2C19—epilepsy syndrome	4.9e-05	0.00742	CrCbGaD
Levorphanol—Rash—Topiramate—epilepsy syndrome	4.87e-05	0.000222	CcSEcCtD
Levorphanol—Dermatitis—Topiramate—epilepsy syndrome	4.87e-05	0.000222	CcSEcCtD
Levorphanol—Nausea—Topiramate—epilepsy syndrome	4.59e-05	0.000209	CcSEcCtD
Levorphanol—Morphine—ABCB1—epilepsy syndrome	4.25e-05	0.00643	CrCbGaD
Levorphanol—Estrone—ALB—epilepsy syndrome	3.59e-05	0.00543	CrCbGaD
Levorphanol—Dextromethorphan—ABCB1—epilepsy syndrome	3.57e-05	0.0054	CrCbGaD
Levorphanol—Estrone—ABCB1—epilepsy syndrome	3.43e-05	0.00518	CrCbGaD
Levorphanol—Estradiol—ALB—epilepsy syndrome	2.72e-05	0.00412	CrCbGaD
Levorphanol—Estradiol—ABCB1—epilepsy syndrome	2.6e-05	0.00393	CrCbGaD
Levorphanol—OPRM1—Signaling by GPCR—SST—epilepsy syndrome	2.35e-05	0.000228	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—CCR2—epilepsy syndrome	2.35e-05	0.000228	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—OPRM1—epilepsy syndrome	2.33e-05	0.000226	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—HTR7—epilepsy syndrome	2.33e-05	0.000226	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—AVP—epilepsy syndrome	2.32e-05	0.000225	CbGpPWpGaD
Levorphanol—OPRM1—GPCR ligand binding—POMC—epilepsy syndrome	2.31e-05	0.000224	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—ADRA2A—epilepsy syndrome	2.3e-05	0.000223	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CX3CR1—epilepsy syndrome	2.27e-05	0.00022	CbGpPWpGaD
Levorphanol—OPRM1—GPCR ligand binding—CCL2—epilepsy syndrome	2.26e-05	0.000219	CbGpPWpGaD
Levorphanol—OPRD1—GPCR downstream signaling—CCR5—epilepsy syndrome	2.25e-05	0.000218	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—GNAO1—epilepsy syndrome	2.25e-05	0.000218	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—OPRD1—epilepsy syndrome	2.25e-05	0.000218	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—BDKRB1—epilepsy syndrome	2.23e-05	0.000216	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CX3CL1—epilepsy syndrome	2.23e-05	0.000216	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CHRM2—epilepsy syndrome	2.23e-05	0.000216	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—AKT3—epilepsy syndrome	2.22e-05	0.000215	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—BDKRB2—epilepsy syndrome	2.21e-05	0.000214	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—CXCL12—epilepsy syndrome	2.21e-05	0.000214	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—CCR3—epilepsy syndrome	2.2e-05	0.000214	CbGpPWpGaD
Levorphanol—OPRD1—GPCR downstream signaling—HTR2A—epilepsy syndrome	2.2e-05	0.000214	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—CDC42—epilepsy syndrome	2.18e-05	0.000211	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—CNR1—epilepsy syndrome	2.17e-05	0.00021	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—GABBR1—epilepsy syndrome	2.17e-05	0.00021	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—PLCB1—epilepsy syndrome	2.16e-05	0.00021	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CHRM1—epilepsy syndrome	2.16e-05	0.000209	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—GRM1—epilepsy syndrome	2.16e-05	0.000209	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—PDYN—epilepsy syndrome	2.16e-05	0.000209	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CCR7—epilepsy syndrome	2.16e-05	0.000209	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—NPY—epilepsy syndrome	2.15e-05	0.000208	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—ATP2A2—epilepsy syndrome	2.15e-05	0.000208	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—HTR7—epilepsy syndrome	2.12e-05	0.000205	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—AVP—epilepsy syndrome	2.11e-05	0.000204	CbGpPWpGaD
Levorphanol—OPRD1—GPCR downstream signaling—AGT—epilepsy syndrome	2.09e-05	0.000203	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—HRH3—epilepsy syndrome	2.08e-05	0.000201	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—HSPB1—epilepsy syndrome	2.07e-05	0.000201	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—OXT—epilepsy syndrome	2.07e-05	0.000201	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—CCL3—epilepsy syndrome	2.07e-05	0.000201	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—CXCL2—epilepsy syndrome	2.07e-05	0.000201	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—CRH—epilepsy syndrome	2.07e-05	0.000201	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—HBEGF—epilepsy syndrome	2.05e-05	0.000199	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—OPRM1—epilepsy syndrome	2.05e-05	0.000198	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—CCR5—epilepsy syndrome	2.04e-05	0.000198	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—CDC42—epilepsy syndrome	2.03e-05	0.000196	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—GFAP—epilepsy syndrome	2.03e-05	0.000196	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—GAL—epilepsy syndrome	2.03e-05	0.000196	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—AKT3—epilepsy syndrome	2.02e-05	0.000196	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CASP2—epilepsy syndrome	2e-05	0.000194	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CHRM3—epilepsy syndrome	2e-05	0.000194	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—GRM5—epilepsy syndrome	2e-05	0.000194	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—HTR2A—epilepsy syndrome	2e-05	0.000194	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—CCR5—epilepsy syndrome	1.97e-05	0.000191	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—AVP—epilepsy syndrome	1.96e-05	0.00019	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CCR3—epilepsy syndrome	1.93e-05	0.000187	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—HTR2A—epilepsy syndrome	1.93e-05	0.000187	CbGpPWpGaD
Levorphanol—OPRD1—GPCR downstream signaling—PRKCB—epilepsy syndrome	1.93e-05	0.000187	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—PTK2B—epilepsy syndrome	1.93e-05	0.000187	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—TSC1—epilepsy syndrome	1.93e-05	0.000187	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CX3CR1—epilepsy syndrome	1.92e-05	0.000186	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—AGT—epilepsy syndrome	1.9e-05	0.000184	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CHRM2—epilepsy syndrome	1.88e-05	0.000183	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CX3CL1—epilepsy syndrome	1.88e-05	0.000183	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—BDKRB1—epilepsy syndrome	1.88e-05	0.000183	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—NPY—epilepsy syndrome	1.88e-05	0.000183	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—ATP2A2—epilepsy syndrome	1.88e-05	0.000183	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—CCR2—epilepsy syndrome	1.87e-05	0.000182	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—NTRK2—epilepsy syndrome	1.87e-05	0.000182	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—SST—epilepsy syndrome	1.87e-05	0.000182	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—DUSP6—epilepsy syndrome	1.86e-05	0.00018	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—CDC42—epilepsy syndrome	1.84e-05	0.000178	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—ADRA2A—epilepsy syndrome	1.83e-05	0.000178	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—AGT—epilepsy syndrome	1.83e-05	0.000178	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—GABBR1—epilepsy syndrome	1.83e-05	0.000178	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—PLAT—epilepsy syndrome	1.83e-05	0.000177	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CXCL2—epilepsy syndrome	1.82e-05	0.000176	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—HSPB1—epilepsy syndrome	1.82e-05	0.000176	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—OXT—epilepsy syndrome	1.82e-05	0.000176	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CCL3—epilepsy syndrome	1.82e-05	0.000176	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CRH—epilepsy syndrome	1.82e-05	0.000176	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—CCR5—epilepsy syndrome	1.79e-05	0.000174	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—AVP—epilepsy syndrome	1.78e-05	0.000173	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—BDKRB2—epilepsy syndrome	1.76e-05	0.000171	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—CXCL12—epilepsy syndrome	1.76e-05	0.000171	CbGpPWpGaD
Levorphanol—OPRD1—GPCR downstream signaling—POMC—epilepsy syndrome	1.76e-05	0.000171	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—HRH3—epilepsy syndrome	1.76e-05	0.00017	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—HTR2A—epilepsy syndrome	1.75e-05	0.00017	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—PRKCB—epilepsy syndrome	1.75e-05	0.00017	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—IL6ST—epilepsy syndrome	1.75e-05	0.000169	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—JUNB—epilepsy syndrome	1.73e-05	0.000168	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—CNR1—epilepsy syndrome	1.73e-05	0.000168	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—PLCB1—epilepsy syndrome	1.72e-05	0.000167	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—PRKCB—epilepsy syndrome	1.69e-05	0.000164	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—TSC1—epilepsy syndrome	1.69e-05	0.000164	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—PTK2B—epilepsy syndrome	1.69e-05	0.000164	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—HTR7—epilepsy syndrome	1.69e-05	0.000164	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—CCR5—epilepsy syndrome	1.67e-05	0.000162	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—AGT—epilepsy syndrome	1.66e-05	0.000161	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—SST—epilepsy syndrome	1.64e-05	0.000159	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—NTRK2—epilepsy syndrome	1.64e-05	0.000159	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CCR2—epilepsy syndrome	1.64e-05	0.000159	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—HBEGF—epilepsy syndrome	1.64e-05	0.000159	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CCR3—epilepsy syndrome	1.63e-05	0.000158	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—HTR2A—epilepsy syndrome	1.63e-05	0.000158	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—DUSP6—epilepsy syndrome	1.63e-05	0.000158	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—ADRA2A—epilepsy syndrome	1.61e-05	0.000156	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—AKT3—epilepsy syndrome	1.61e-05	0.000156	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—PLAT—epilepsy syndrome	1.6e-05	0.000155	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—POMC—epilepsy syndrome	1.6e-05	0.000155	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—NPY—epilepsy syndrome	1.59e-05	0.000154	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—ATP2A2—epilepsy syndrome	1.59e-05	0.000154	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—ADAM10—epilepsy syndrome	1.57e-05	0.000152	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—CCL2—epilepsy syndrome	1.56e-05	0.000152	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—AGT—epilepsy syndrome	1.55e-05	0.00015	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CXCL12—epilepsy syndrome	1.54e-05	0.00015	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—BDKRB2—epilepsy syndrome	1.54e-05	0.00015	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—POMC—epilepsy syndrome	1.54e-05	0.00015	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—PRKCB—epilepsy syndrome	1.54e-05	0.000149	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CRH—epilepsy syndrome	1.54e-05	0.000149	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—HSPB1—epilepsy syndrome	1.54e-05	0.000149	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—OXT—epilepsy syndrome	1.54e-05	0.000149	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CCL3—epilepsy syndrome	1.54e-05	0.000149	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CXCL2—epilepsy syndrome	1.54e-05	0.000149	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—IL6ST—epilepsy syndrome	1.53e-05	0.000148	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—JUNB—epilepsy syndrome	1.52e-05	0.000147	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CNR1—epilepsy syndrome	1.52e-05	0.000147	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—CCR5—epilepsy syndrome	1.51e-05	0.000147	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—PLCB1—epilepsy syndrome	1.51e-05	0.000146	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—S100B—epilepsy syndrome	1.49e-05	0.000144	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—HTR2A—epilepsy syndrome	1.48e-05	0.000144	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—HTR7—epilepsy syndrome	1.48e-05	0.000143	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—SOCS3—epilepsy syndrome	1.47e-05	0.000143	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—CDC42—epilepsy syndrome	1.47e-05	0.000142	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—HBEGF—epilepsy syndrome	1.44e-05	0.000139	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—PRKCB—epilepsy syndrome	1.43e-05	0.000139	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—TSC1—epilepsy syndrome	1.43e-05	0.000138	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—PTK2B—epilepsy syndrome	1.43e-05	0.000138	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—AVP—epilepsy syndrome	1.42e-05	0.000138	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—AKT3—epilepsy syndrome	1.41e-05	0.000137	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—AGT—epilepsy syndrome	1.41e-05	0.000136	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—POMC—epilepsy syndrome	1.4e-05	0.000136	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—SST—epilepsy syndrome	1.39e-05	0.000135	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CCR2—epilepsy syndrome	1.39e-05	0.000135	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—NTRK2—epilepsy syndrome	1.39e-05	0.000135	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—ADAM10—epilepsy syndrome	1.38e-05	0.000133	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—DUSP6—epilepsy syndrome	1.38e-05	0.000133	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—CCL2—epilepsy syndrome	1.37e-05	0.000133	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—ADRA2A—epilepsy syndrome	1.36e-05	0.000132	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—PLAT—epilepsy syndrome	1.35e-05	0.000131	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—HES1—epilepsy syndrome	1.34e-05	0.00013	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—FYN—epilepsy syndrome	1.31e-05	0.000127	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—BDKRB2—epilepsy syndrome	1.31e-05	0.000127	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CXCL12—epilepsy syndrome	1.31e-05	0.000127	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—POMC—epilepsy syndrome	1.3e-05	0.000126	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—S100B—epilepsy syndrome	1.3e-05	0.000126	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—H2AFX—epilepsy syndrome	1.3e-05	0.000126	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—PRKCB—epilepsy syndrome	1.3e-05	0.000126	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—MEF2C—epilepsy syndrome	1.3e-05	0.000126	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—IL6ST—epilepsy syndrome	1.29e-05	0.000125	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—SOCS3—epilepsy syndrome	1.29e-05	0.000125	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CDC42—epilepsy syndrome	1.29e-05	0.000125	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—JUNB—epilepsy syndrome	1.28e-05	0.000124	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CNR1—epilepsy syndrome	1.28e-05	0.000124	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—PLCB1—epilepsy syndrome	1.28e-05	0.000124	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—YWHAZ—epilepsy syndrome	1.26e-05	0.000122	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—HTR7—epilepsy syndrome	1.25e-05	0.000121	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—AVP—epilepsy syndrome	1.25e-05	0.000121	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—NGF—epilepsy syndrome	1.24e-05	0.00012	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—HBEGF—epilepsy syndrome	1.21e-05	0.000118	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—CCR5—epilepsy syndrome	1.21e-05	0.000117	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—AKT3—epilepsy syndrome	1.19e-05	0.000115	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—POMC—epilepsy syndrome	1.18e-05	0.000115	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—HTR2A—epilepsy syndrome	1.18e-05	0.000115	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—HES1—epilepsy syndrome	1.18e-05	0.000114	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—ADAM10—epilepsy syndrome	1.16e-05	0.000113	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—CCL2—epilepsy syndrome	1.16e-05	0.000112	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—FYN—epilepsy syndrome	1.15e-05	0.000111	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—H2AFX—epilepsy syndrome	1.14e-05	0.000111	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—MEF2C—epilepsy syndrome	1.14e-05	0.00011	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—TSC2—epilepsy syndrome	1.12e-05	0.000109	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—AGT—epilepsy syndrome	1.12e-05	0.000109	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—YWHAZ—epilepsy syndrome	1.1e-05	0.000107	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—S100B—epilepsy syndrome	1.1e-05	0.000107	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—APOE—epilepsy syndrome	1.1e-05	0.000106	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—SOCS3—epilepsy syndrome	1.09e-05	0.000106	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—NGF—epilepsy syndrome	1.09e-05	0.000106	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CDC42—epilepsy syndrome	1.09e-05	0.000105	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—KDR—epilepsy syndrome	1.08e-05	0.000104	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CCR5—epilepsy syndrome	1.06e-05	0.000103	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—AVP—epilepsy syndrome	1.05e-05	0.000102	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—HTR2A—epilepsy syndrome	1.04e-05	0.0001	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—PRKCB—epilepsy syndrome	1.04e-05	0.0001	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—IL6ST—epilepsy syndrome	1.03e-05	0.0001	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—HES1—epilepsy syndrome	9.95e-06	9.65e-05	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—TSC2—epilepsy syndrome	9.84e-06	9.54e-05	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—AGT—epilepsy syndrome	9.83e-06	9.53e-05	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—FYN—epilepsy syndrome	9.68e-06	9.38e-05	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—H2AFX—epilepsy syndrome	9.64e-06	9.35e-05	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—APOE—epilepsy syndrome	9.63e-06	9.34e-05	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—MEF2C—epilepsy syndrome	9.63e-06	9.33e-05	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—POMC—epilepsy syndrome	9.44e-06	9.15e-05	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—KDR—epilepsy syndrome	9.44e-06	9.15e-05	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—YWHAZ—epilepsy syndrome	9.3e-06	9.02e-05	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—CCL2—epilepsy syndrome	9.23e-06	8.95e-05	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—NGF—epilepsy syndrome	9.2e-06	8.92e-05	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—PRKCB—epilepsy syndrome	9.08e-06	8.81e-05	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—IL6ST—epilepsy syndrome	9.05e-06	8.77e-05	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CCR5—epilepsy syndrome	8.95e-06	8.67e-05	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—HTR2A—epilepsy syndrome	8.76e-06	8.49e-05	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—FGF2—epilepsy syndrome	8.35e-06	8.09e-05	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—TSC2—epilepsy syndrome	8.32e-06	8.06e-05	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—AGT—epilepsy syndrome	8.31e-06	8.05e-05	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—POMC—epilepsy syndrome	8.28e-06	8.02e-05	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—APOE—epilepsy syndrome	8.14e-06	7.89e-05	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CCL2—epilepsy syndrome	8.1e-06	7.85e-05	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—KDR—epilepsy syndrome	7.98e-06	7.73e-05	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—RELA—epilepsy syndrome	7.75e-06	7.51e-05	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—PRKCB—epilepsy syndrome	7.68e-06	7.44e-05	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—IL6ST—epilepsy syndrome	7.65e-06	7.41e-05	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—MTOR—epilepsy syndrome	7.6e-06	7.36e-05	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—FGF2—epilepsy syndrome	7.32e-06	7.09e-05	CbGpPWpGaD
Levorphanol—OPRD1—GPCR downstream signaling—AKT1—epilepsy syndrome	7.05e-06	6.84e-05	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—POMC—epilepsy syndrome	6.99e-06	6.78e-05	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—CASP3—epilepsy syndrome	6.99e-06	6.77e-05	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CCL2—epilepsy syndrome	6.84e-06	6.63e-05	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—RELA—epilepsy syndrome	6.79e-06	6.58e-05	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—JUN—epilepsy syndrome	6.79e-06	6.58e-05	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—MTOR—epilepsy syndrome	6.66e-06	6.46e-05	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—MMP9—epilepsy syndrome	6.6e-06	6.4e-05	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—AKT1—epilepsy syndrome	6.4e-06	6.21e-05	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—FGF2—epilepsy syndrome	6.18e-06	6e-05	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—AKT1—epilepsy syndrome	6.18e-06	5.99e-05	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CASP3—epilepsy syndrome	6.13e-06	5.94e-05	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—SRC—epilepsy syndrome	6.09e-06	5.9e-05	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—JUN—epilepsy syndrome	5.95e-06	5.77e-05	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—VEGFA—epilepsy syndrome	5.93e-06	5.75e-05	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—MMP9—epilepsy syndrome	5.79e-06	5.61e-05	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—RELA—epilepsy syndrome	5.74e-06	5.57e-05	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—MTOR—epilepsy syndrome	5.63e-06	5.46e-05	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—AKT1—epilepsy syndrome	5.62e-06	5.44e-05	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—SRC—epilepsy syndrome	5.34e-06	5.17e-05	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—AKT1—epilepsy syndrome	5.23e-06	5.07e-05	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—VEGFA—epilepsy syndrome	5.2e-06	5.04e-05	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CASP3—epilepsy syndrome	5.18e-06	5.02e-05	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—JUN—epilepsy syndrome	5.03e-06	4.88e-05	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—MMP9—epilepsy syndrome	4.89e-06	4.74e-05	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—AKT1—epilepsy syndrome	4.75e-06	4.6e-05	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—SRC—epilepsy syndrome	4.51e-06	4.37e-05	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—VEGFA—epilepsy syndrome	4.39e-06	4.26e-05	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—AKT1—epilepsy syndrome	3.78e-06	3.67e-05	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—AKT1—epilepsy syndrome	3.32e-06	3.22e-05	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—AKT1—epilepsy syndrome	2.8e-06	2.72e-05	CbGpPWpGaD
